Literature DB >> 27495784

[Pathology of lung cancer].

D Theegarten1, T Hager2.   

Abstract

Lung cancer is the leading cause of cancer death in men and the second most frequent cause in women. The pathology of lung tumors is of special relevance concerning therapy and prognosis and current classification systems have to be taken into consideration. The results of molecular tissue subtyping allow further classification and therapeutic options. The histological entities are mainly associated with typical X‑ray morphological features.

Entities:  

Keywords:  Classification; Histological typing; Radiomorphological alterations; Subtypes; Therapeutic options

Mesh:

Year:  2016        PMID: 27495784     DOI: 10.1007/s00117-016-0154-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  15 in total

Review 1.  [Rapid on-site evaluation (ROSE) in cytological diagnostics of pulmonary and mediastinal diseases].

Authors:  J Wohlschläger; K Darwiche; S Ting; T Hager; L Freitag; K W Schmid; H Kühl; D Theegarten
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

2.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15----q23.

Authors:  F Galland; M Stefanova; M Lafage; D Birnbaum
Journal:  Cytogenet Cell Genet       Date:  1992

Review 4.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

5.  Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imaging.

Authors:  Frederik Großerueschkamp; Angela Kallenbach-Thieltges; Thomas Behrens; Thomas Brüning; Matthias Altmayer; Georgios Stamatis; Dirk Theegarten; Klaus Gerwert
Journal:  Analyst       Date:  2015-04-07       Impact factor: 4.616

6.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Authors:  Arne Warth; Thomas Muley; Michael Meister; Albrecht Stenzinger; Michael Thomas; Peter Schirmacher; Philipp A Schnabel; Jan Budczies; Hans Hoffmann; Wilko Weichert
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

7.  Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.

Authors:  Scott N Gettinger; Leora Horn; Leena Gandhi; David R Spigel; Scott J Antonia; Naiyer A Rizvi; John D Powderly; Rebecca S Heist; Richard D Carvajal; David M Jackman; Lecia V Sequist; David C Smith; Philip Leming; David P Carbone; Mary C Pinder-Schenck; Suzanne L Topalian; F Stephen Hodi; Jeffrey A Sosman; Mario Sznol; David F McDermott; Drew M Pardoll; Vindira Sankar; Christoph M Ahlers; Mark Salvati; Jon M Wigginton; Matthew D Hellmann; Georgia D Kollia; Ashok K Gupta; Julie R Brahmer
Journal:  J Clin Oncol       Date:  2015-04-20       Impact factor: 44.544

8.  Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center.

Authors:  Marcel Wiesweg; Saskia Ting; Henning Reis; Karl Worm; Stefan Kasper; Mitra Tewes; Anja Welt; Heike Richly; Johannes Meiler; Sebastian Bauer; Jörg Hense; Thomas C Gauler; Jens Köhler; Wilfried E Eberhardt; Kaid Darwiche; Lutz Freitag; Georgios Stamatis; Frank Breitenbücher; Jeremias Wohlschlaeger; Dirk Theegarten; Cordula Derks; Diana Cortes-Incio; Gabriele Linden; Silke Skottky; Peter Lütkes; Alexander Dechêne; Andreas Paul; Peter Markus; Kurt W Schmid; Martin Schuler
Journal:  Eur J Cancer       Date:  2013-07-19       Impact factor: 9.162

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

10.  Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma.

Authors:  Mathieu Lederlin; Michael Puderbach; Thomas Muley; Philipp A Schnabel; Albrecht Stenzinger; Hans-Ulrich Kauczor; Claus Peter Heussel; Felix J F Herth; Hans Hoffmann; Hendrik Dienemann; Wilko Weichert; Arne Warth
Journal:  Eur Respir J       Date:  2012-07-26       Impact factor: 16.671

View more
  3 in total

1.  The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.

Authors:  Mingfei Zuo; Lan Yao; Lijuan Wen; Jianfei Shen; Na Zhang; Tian Bai; Qicheng Huang
Journal:  World J Surg Oncol       Date:  2021-09-01       Impact factor: 2.754

2.  Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer.

Authors:  Hailu Fu; Huijun Gao; Xiaoyu Qi; Lei Zhao; Donghua Wu; Yuxin Bai; Huimin Li; Xuan Liu; Jun Hu; Shujuan Shao
Journal:  Cancer Commun (Lond)       Date:  2018-05-08

3.  Evaluation of the association between vitamin D and lung cancer skin metastasis: A protocol for systematic review.

Authors:  Dan Zhao; Tao Wang; Yu-Feng Li; Jian-Wei Huang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.